These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 22099200

  • 1. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN, Liang L, Cai XD, Li Z, Bai M, Gu CP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
    [Abstract] [Full Text] [Related]

  • 2. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P, Suphasit R, Mahachoklertwattana P.
    Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
    [Abstract] [Full Text] [Related]

  • 3. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK, Fan X, Tang Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
    [Abstract] [Full Text] [Related]

  • 4. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function.
    Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R.
    J Clin Endocrinol Metab; 2008 Jan; 93(1):190-5. PubMed ID: 17940112
    [Abstract] [Full Text] [Related]

  • 5. Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty.
    Massart F, Federico G, Harrell JC, Saggese G.
    Neuroendocrinology; 2009 Jan; 90(3):307-14. PubMed ID: 19641297
    [Abstract] [Full Text] [Related]

  • 6. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.
    Orv Hetil; 2012 Mar 18; 153(11):418-24. PubMed ID: 22390866
    [Abstract] [Full Text] [Related]

  • 7. Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height.
    Chiocca E, Dati E, Baroncelli GI, Mora S, Parrini D, Erba P, Bertelloni S.
    Neuroendocrinology; 2009 Mar 18; 89(4):441-7. PubMed ID: 19176945
    [Abstract] [Full Text] [Related]

  • 8. Near final adult height, and body mass index in overweight/obese and normal-weight children with idiopathic central precocious puberty and treated with gonadotropin-releasing hormone analogs.
    Sinthuprasith P, Dejkhamron P, Wejaphikul K, Unachak K.
    J Pediatr Endocrinol Metab; 2019 Dec 18; 32(12):1369-1375. PubMed ID: 31605579
    [Abstract] [Full Text] [Related]

  • 9. [Effects of gonadotropin releasing hormone analog and growth hormone on height in girls with idiopathic central precocious puberty].
    Wang CL, Liang L, Liu PN, Jin XJ, Chen LQ, Yang F, Lian Q, Chen RM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jan 18; 16(1):25-30. PubMed ID: 24461173
    [Abstract] [Full Text] [Related]

  • 10. Does GnRH analog improve the final height in Thai girls with idiopathic central precocious puberty?
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S, Trinavarat P.
    J Med Assoc Thai; 2001 Jun 18; 84 Suppl 1():S51-6. PubMed ID: 11529380
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of GnRH agonist treatment on body mass index in girls with idiopathic central precocious puberty.
    Vuralli D, Ozon ZA, Gonc EN, Alikasifoglu A, Kandemir N.
    J Pediatr Endocrinol Metab; 2020 Jan 28; 33(1):99-105. PubMed ID: 31804960
    [Abstract] [Full Text] [Related]

  • 12. The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study.
    Magiakou MA, Manousaki D, Papadaki M, Hadjidakis D, Levidou G, Vakaki M, Papaefstathiou A, Lalioti N, Kanaka-Gantenbein C, Piaditis G, Chrousos GP, Dacou-Voutetakis C.
    J Clin Endocrinol Metab; 2010 Jan 28; 95(1):109-17. PubMed ID: 19897682
    [Abstract] [Full Text] [Related]

  • 13. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D, Karavani G, Hirsch HJ, Strich D.
    J Pediatr; 2013 Aug 28; 163(2):532-6. PubMed ID: 23485026
    [Abstract] [Full Text] [Related]

  • 14. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B, Julius JR, Blethen SL.
    Pediatrics; 1999 Oct 28; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [Abstract] [Full Text] [Related]

  • 15. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF, McNeill E, Young D, Donaldson MD.
    Clin Endocrinol (Oxf); 2004 Nov 28; 61(5):626-34. PubMed ID: 15521967
    [Abstract] [Full Text] [Related]

  • 16. Combined treatment with gonadotropin-releasing hormone analog and growth hormone in central precocious puberty.
    Pasquino AM, Municchi G, Pucarelli I, Segni M, Mancini MA, Troiani S.
    J Clin Endocrinol Metab; 1996 Mar 28; 81(3):948-51. PubMed ID: 8772556
    [Abstract] [Full Text] [Related]

  • 17. Changes in Body Mass Index in Girls with Idiopathic Central Precocious Puberty under Gonadotropin-Releasing Hormone Analogue Therapy: The Spanish Registry.
    Corripio R, Soriano-Guillén L, Herrero FJ, Cañete R, Castro-Feijoó L, Escribano A, Espino R, Labarta JI, Argente J.
    Horm Res Paediatr; 2016 Mar 28; 86(3):154-160. PubMed ID: 27529349
    [Abstract] [Full Text] [Related]

  • 18. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J, Reynaud R, Czernichow P.
    J Pediatr; 2000 Dec 28; 137(6):819-25. PubMed ID: 11113839
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M, Bacopoulou I, Savva SC, Skordis N.
    Indian Pediatr; 2007 Jul 28; 44(7):497-502. PubMed ID: 17684302
    [Abstract] [Full Text] [Related]

  • 20. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
    Li YH, Zhu SY, Ma HM, Su Z, Chen HS, Chen QL, Gu YF, Du ML.
    Zhonghua Er Ke Za Zhi; 2013 Nov 28; 51(11):807-12. PubMed ID: 24484553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.